Takeda Pharmaceuticals America
Takeda Pharmaceuticals America Inc. Political Action Committee
Lobbying: all issues, rounded to the nearest $10,000. Two filers, same 21 months. This PAC gives money raised from the company’s employees; the company itself can’t give to campaigns from its treasury.
Spend by quarter Pro
Free account See ProWhat they lobby on
MethodTakeda Pharmaceuticals America reported federal lobbying in 8 of the last 8 quarters (Q4 2024 to Q3 2026), with its own in-house lobbyists and 7 outside firms. What follows is what the filings say it lobbied on, not which way.
Issue areas ranked by quarters filedQ4 24 → Q3 26
- Copyright/Patent/Trademark8/8
- Defense8/8
- Health Issues8/8
- Medicare/Medicaid8/8
- Taxation/Internal Revenue Code8/8
Trade (domestic/foreign) 8 of 8 · Budget/Appropriations 7 of 8 · 2 more · Show all 9
- Trade (domestic/foreign)8/8
- Budget/Appropriations7/8
- Pharmacy5/8
- Environment/Superfund2/8
Bills named in the filings 51 bills, this period
- H.R. 4299 Protecting Patient Access to Cancer and Complex Therapies Act13 filings
- H.R. 1 An act to provide for reconciliation pursuant to title II of H. Con. Res. 14. Broad bill13 filings
- S. 832 EPIC Act of 20257 filings
- S. 891 Bipartisan Health Care Act7 filings
- H.R. 946 ORPHAN Cures Act5 filings
46 more, 37 named in only one filing · Show all 51
- H.R. 4229 To amend the Impoundment Control Act of 1974 to require prior approval from Congress before the Comptroller General may pursue a civil action under such Act, and for other purposes.4 filings
- H.R. 2214 DRUG Act3 filings
- H.R. 7299 To designate the facility of the United States Postal Service located at 2600 Michigan Avenue in Kissimmee, Florida, as the "Robert Guevara Post Office Building".2 filings
- S. 1375 / H.R. 830, 118th HELP Copays Act2 filings
- S. 1542 / H.R. 6283, 118th DRUG Act2 filings
- S. 3131 / H.R. 5539, 118th ORPHAN Cures Act2 filings
- S. 694 / H.R. 1476 PLASMA Act2 filings
- H.R. 10445, 118th Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 Broad bill2 filings
- H.R. 5378, 118th Lower Costs, More Transparency Act Broad bill2 filings
- H.R. 2528 Association Health Plans Act1 filing
- H.R. 2534, 118th PROTECT 340B Act of 20231 filing
- H.R. 2630, 118th Safe Step Act1 filing
- H.R. 3285, 118th Fairness for Patient Medications Act1 filing
- H.R. 3665, 118th Defending American Jobs and Investment Act1 filing
- H.R. 5256 340B ACCESS Act1 filing
- H.R. 6609 Pharmacists Fight Back in Medicare and Medicaid Act1 filing
- H.R. 7085, 118th BIOSECURE Act1 filing
- H.R. 7174, 118th To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.1 filing
- H.R. 7837 Most Favored Patient Act of 20261 filing
- H.R. 8239, 118th SEC Regulatory Accountability Act1 filing
- H.R. 8269 CLEAR LABELS Act1 filing
- H.R. 8574, 118th 340B ACCESS Act1 filing
- H.R. 9599 SECURE 340B Act1 filing
- S. 1040 Drug Competition Enhancement Act1 filing
- S. 1095 Stop STALLING Act1 filing
- S. 1096 Preserve Access to Affordable Generics and Biosimilars Act1 filing
- S. 1954 Biosimilar Red Tape Elimination Act1 filing
- S. 2305, 118th Biosimilar Red Tape Elimination Act1 filing
- S. 2372 / H.R. 4581 340B PATIENTS Act of 20251 filing
- S. 2658 Medication Affordability and Patent Integrity Act1 filing
- S. 2973, 118th On congress.gov1 filing
- S. 3385, 118th A bill to prohibit contracting with certain biotechnology providers.1 filing
- S. 3430, 118th On congress.gov1 filing
- H.Con.Res. 14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034. Broad bill1 filing
- H.R. 10545, 118th American Relief Act, 2025 Broad bill1 filing
- H.R. 1968 Full-Year Continuing Appropriations and Extensions Act, 2025 Broad bill1 filing
- H.R. 2673, 118th American Innovation and R&D Competitiveness Act of 2023 Broad bill1 filing
- H.R. 5376, 118th Share the Savings with Seniors Act Broad bill1 filing
- H.R. 7024, 118th Tax Relief for American Families and Workers Act of 2024 Broad bill1 filing
- H.R. 9747, 118th Continuing Appropriations and Extensions Act, 2025 Broad bill1 filing
- S. 127, 118th Pharmacy Benefit Manager Transparency Act of 2023 Broad bill1 filing
- S. 1339, 118th Pharmacy Benefit Manager Reform Act Broad bill1 filing
- S. 2226 / H.R. 2670, 118th National Defense Authorization Act for Fiscal Year 2024 Broad bill1 filing
- S. 4690 / H.R. 9027, 118th Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025 Broad bill1 filing
- S. 4942 / H.R. 9029, 118th Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025 Broad bill1 filing
- S. 866, 118th American Innovation and Jobs Act Broad bill1 filing
From the filings
“Issues related to drug pricing and reimbursement for prescription drugs; Issues related to H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act”
“Issues relating to HR 4299 and other heath issues.”
Contacted as listed on the filings
- U.S. House
- U.S. Senate
- CMS
- EPA
- OMB
- ITC
- USTR
The House and Senate appear in every quarter; agencies in 5 of 8.
Every filing since 2015 Pro
Free account See ProSource: Lobbying Disclosure Act filings (LD-2) by Takeda Pharmaceuticals America, Senate Office of Public Records. Filings are due 20 days after each quarter ends.
From FEC filings: direct gifts this PAC reported, net of refunds · How we count
Gave directly to 44 sitting members of Congress and 3 other candidates in 2025–26.
See every candidate and member Takeda Pharmaceuticals America gave to directly, how much, and how its money splits between the parties.
This part is in Pro. A free account lets you follow up to 3 people and get a weekly email about them; upgrade whenever you need more.
Create a free account See what Pro adds Log in